###begin article-title 0
The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing
###end article-title 0
###begin p 1
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 716 727 <span type="species:ncbi:205488">Ebola virus</span>
###xml 852 857 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 901 906 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 962 967 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1042 1056 <span type="species:ncbi:10245">Vaccinia virus</span>
###xml 1073 1090 <span type="species:ncbi:11320">influenza A virus</span>
###xml 1137 1142 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
RNA silencing or interference (RNAi) is a gene regulation mechanism in eukaryotes that controls cell differentiation and developmental processes via expression of microRNAs. RNAi also serves as an innate antiviral defence response in plants, nematodes, and insects. This antiviral response is triggered by virus-specific double-stranded RNA molecules (dsRNAs) that are produced during infection. To overcome antiviral RNAi responses, many plant and insect viruses encode RNA silencing suppressors (RSSs) that enable them to replicate at higher titers. Recently, several human viruses were shown to encode RSSs, suggesting that RNAi also serves as an innate defence response in mammals. Here, we demonstrate that the Ebola virus VP35 protein is a suppressor of RNAi in mammalian cells and that its RSS activity is functionally equivalent to that of the HIV-1 Tat protein. We show that VP35 can replace HIV-1 Tat and thereby support the replication of a Tat-minus HIV-1 variant. The VP35 dsRNA-binding domain is required for this RSS activity. Vaccinia virus E3L protein and influenza A virus NS1 protein are also capable of replacing the HIV-1 Tat RSS function. These findings support the hypothesis that RNAi is part of the innate antiviral response in mammalian cells. Moreover, the results indicate that RSSs play a critical role in mammalian virus replication.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 643 654 <span type="species:ncbi:205488">Ebola virus</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 773 778 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cells have evolved mechanisms to protect themselves from virus infection. A well-known antiviral mechanism in mammals is the interferon (IFN) response of the innate immune system. In plants, insects, and worms, RNA silencing or RNA interference (RNAi) is a strong antiviral defence mechanism. It is still debated whether RNAi is also used as an antiviral mechanism in mammals. Many mammalian viruses encode essential factors that suppress the innate antiviral responses of the host. Such innate immunity suppressor proteins, or IFN antagonists, have recently been reported to also suppress RNAi in mammalian cells. We now demonstrate that the Ebola virus VP35 protein, a known IFN antagonist, suppresses RNAi in human cells. In addition, VP35 restores the production of an HIV-1 variant with a defective RNAi suppressor Tat protein. These results indicate that RNAi is part of the innate antiviral defence response in mammals and that viruses need to counteract this response in order to replicate. Whereas RNAi and INF act in concert to prevent the infection of mammalian cells, the invading viruses encode a protein that counteracts both defence mechanisms.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b001">1</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b004">4</xref>
###xml 826 827 826 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b005">5</xref>
###xml 1225 1226 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b006">6</xref>
###xml 1425 1426 1425 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b007">7</xref>
###xml 1309 1329 <span type="species:ncbi:11988">turnip crinkle virus</span>
An important criterion for productive virus infection is that the virus evades host antiviral immune responses. In plants, insects, and nematodes, the basis of these protective immune responses is formed by the RNA interference (RNAi) mechanism [1-4]. During virus infection, RNAi against the virus is activated by the production of virus-specific double-stranded RNAs (dsRNAs). These virus-specific dsRNAs are processed into small interfering RNAs (siRNAs; a 21-nucleotide dsRNA duplex) by the RNAse III-like endonuclease-denoted Dicer. Subsequently, one strand of the siRNA duplex, the guide-strand, is incorporated into the RNA-induced silencing complex (RISC) to target viral mRNAs bearing complementary sequences for destruction. To overcome this antiviral RNAi response, viruses encode RNA silencing suppressors (RSSs) [5]. For plant viruses, RSSs were first described as pathogenicity factors that contribute to high virus accumulation and disease. One of the best-characterized suppressors is the tombusvirus-encoded P19 protein. This protein, which suppresses RNAi both in plants and mammalian cells, blocks RNAi by binding siRNAs via its dsRNA-binding domain, thereby sequestering the siRNAs from the RNAi pathway [6]. Another way to block RNAi is via inhibition of Dicer activity. For example, the turnip crinkle virus P83 protein was recently shown to specifically block the activity of the Dicer-like 4 protein [7].
###end p 6
###begin p 7
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b008">8</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b009">9</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b010">10</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b012">12</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b013">13</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b014">14</xref>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 450 485 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 487 492 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of RNAi in mammalian cells, either by transfection of synthetic siRNAs or by endogenous expression of short hairpin RNAs (shRNAs), is a potent new antiviral tool [8]. These findings support the idea that RNAi is part of the innate immune system in mammals. However, in most cases, virus-specific siRNAs could not be detected in virus-infected mammalian cells [9]. So far, virus-specific siRNAs have only been identified in human cells for human immunodeficiency virus type 1 (HIV-1) and the LINE-1 retrotransposon [10-12]. It has been argued that mammalian cells do not need RNAi-based antiviral responses because they have acquired the interferon (IFN) response [13]. However, all other eukaryotes also evolved innate antiviral defence responses. For instance, plants have pattern recognition receptors, and virus recognition leads to apoptosis and the systemic acquired resistance response that is analogous to the IFN response in mammalian cells [14]. Similar to RNAi, the IFN pathway is triggered by cytoplasmic viral dsRNAs and acts as a sensitive and potent antiviral response that is involved in innate and subsequent adaptive immunity.
###end p 7
###begin p 8
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b011">11</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b015">15</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b018">18</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b017">17</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b016">16</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b019">19</xref>
###xml 1148 1150 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b011">11</xref>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b017">17</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b020">20</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b021">21</xref>
###xml 1353 1355 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b024">24</xref>
###xml 277 294 <span type="species:ncbi:11320">influenza A virus</span>
###xml 306 320 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 332 349 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 364 375 <span type="species:ncbi:11963">foamy virus</span>
###xml 404 409 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 704 721 <span type="species:ncbi:12287">Flock house virus</span>
###xml 1049 1054 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
If RNAi has an antiviral function in mammals, then the infecting viruses should encode RSSs as they do in plant and insect viruses. Recently, several mammalian viruses have been shown to encode viral factors that exhibit RSS activity in animal cells. These factors include the influenza A virus NS1 (NS1), vaccinia virus E3L (E3L), hepatitis C virus Core, primate foamy virus type 1 (PFV-1) Tas, and the HIV-1 Tat proteins, as well as the adenovirus virus-associated RNAs I and II (VAI and VAII) [11,15-18]. Like plant virus RSSs, these suppressors block induced RNAi against reporter gene constructs. Moreover, NS1 and E3L were able to replace the RNAi suppression function of the b2 protein encoded by Flock house virus and to support virus replication in insect cells [17]. Although most of these viral proteins/RNAs are essential for virus replication, their mode of action is largely unknown. We and others have shown that the adenovirus virus-associated RNAs inhibit RNAi by acting as decoy substrates for Exportin 5, Dicer, and RISC [16,19]. HIV-1 Tat is thought to block Dicer activity, whereas NS1 and E3L may sequester dsRNAs and siRNAs [11,17,20]. Strikingly, all RSS proteins from mammalian viruses possess IFN or protein kinase R (PKR) antagonistic properties, suggesting that RNAi and other innate antiviral responses are interrelated [21-24].
###end p 8
###begin p 9
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b013">13</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b025">25</xref>
###xml 458 463 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 508 513 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 541 552 <span type="species:ncbi:205488">Ebola virus</span>
###xml 554 558 <span type="species:ncbi:205488">EBOV</span>
###xml 640 645 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 804 809 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 960 965 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although there is consensus about the fact that viral factors can indeed block RNAi in mammalian cells, there is an ongoing debate about the significance for viral replication [13]. Because non-viral dsRNA-binding proteins such as the bacterial RNase-III protein can also act as RSSs in plant cells, it is important to determine the contribution of RNAi suppression to virus replication [25]. Here, we show that Tat-mediated RNAi suppression is required for HIV-1 virus production. Using defective Tat-minus HIV-1 mutants, we identified the Ebola virus (EBOV) VP35 protein as a potent RNAi suppressor that is functionally equivalent to the HIV-1 Tat RSS function. Furthermore, we show that the E3L and NS1 proteins can also functionally complement the Tat RSS function and rescue virus production of the HIV-1 Tat-minus mutants. These data support the role of RNAi in innate antiviral responses in mammalian cells and the essential role of RNAi suppression in HIV-1 replication.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Testing Viral IFN Antagonistic Proteins for RNAi Suppression Activity
###end title 11
###begin p 12
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b021">21</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b026">26</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b027">27</xref>
###xml 823 831 819 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g001">Figure 1</xref>
###xml 1165 1166 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1188 1190 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b028">28</xref>
###xml 1211 1212 1207 1208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1265 1266 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1309 1317 1305 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g001">Figure 1</xref>
###xml 133 137 <span type="species:ncbi:205488">EBOV</span>
###xml 212 229 <span type="species:ncbi:11320">influenza A virus</span>
###xml 400 404 <span type="species:ncbi:205488">EBOV</span>
###xml 657 661 <span type="species:ncbi:205488">EBOV</span>
###xml 701 706 <span type="species:ncbi:9606">human</span>
###xml 1103 1123 <span type="species:ncbi:9534">African green monkey</span>
At present, all RSS proteins identified in mammalian viruses have IFN/PKR antagonistic properties. Previously, it was shown that the EBOV IFN antagonist protein VP35 is capable of restoring the replication of an influenza A virus mutant with a large deletion in the NS1 gene [21,26], raising the possibility that VP35 acts as an RSS in mammalian cells. To investigate the RNAi suppressor activity of EBOV VP35, we assayed whether this protein is capable of suppressing shRNA-mediated silencing of a luciferase reporter. HEK293T cells were co-transfected with expression vectors for luciferase and firefly luciferase-specific shRNA (shLuc) [27], and with an EBOV VP35 expression plasmid containing the human EF1alpha promoter. Co-transfection of luciferase with shLuc resulted in a strong decrease of luciferase expression (Figure 1A). Addition of the VP35 expression plasmid suppressed the shRNA-mediated RNAi in a dose-dependent manner and restored luciferase expression. To exclude that the observed effect is caused by the IFN antagonistic properties of VP35, its RSS activity was also determined in African green monkey kidney Vero cells that have a defect (IFN-) in the IFN pathway [28]. As in HEK293T (IFN+) cells, VP35 expression suppressed RNAi in Vero (IFN-) cells and rescued luciferase expression (Figure 1B).
###end p 12
###begin p 13
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b017">17</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b020">20</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b029">29</xref>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g001">Figure 1</xref>
###xml 581 589 581 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g001">Figure 1</xref>
Next, we compared the RSS activity of VP35 with that of NS1 and E3L, which were previously demonstrated to have RSS activity in insect and plant cells [17,20,29]. Because insect and plant cells lack the IFN pathway, the RSS activity was determined both in HEK293T (IFN+) and Vero (IFN-) cells. E3L suppressed RNAi in HEK293T cells, whereas NS1 protein did not (Figure 1C). However, both E3L and NS1 were able to suppress RNAi in Vero cells. The control expression plasmid encoding green fluorescent protein (GFP) did not suppress RNAi-mediated inhibition of luciferase expression (Figure 1D). These data show that VP35, E3L, and NS1 are able to suppress shRNA-induced RNAi in mammalian cells. Possibly, the cell type-dependent RSS activity of NS1 follows from differences in the expression level of certain cellular RNAi co-factors.
###end p 13
###begin title 14
VP35 dsRNA-Binding Capacity Is Required for RSS Activity
###end title 14
###begin p 15
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b030">30</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b030">30</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b032">32</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b033">33</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b034">34</xref>
###xml 443 446 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">304</sup>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">314</sup>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b030">30</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b031">31</xref>
###xml 812 814 812 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1045 1047 1045 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1285 1293 1285 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g002">Figure 2</xref>
###xml 1317 1319 1317 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1524 1532 1524 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g002">Figure 2</xref>
###xml 918 921 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1036 1040 <span type="species:ncbi:205488">EBOV</span>
###xml 1131 1134 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
VP35 has a dsRNA-binding motif with high similarity to the dsRNA-binding domain of the NS1 protein [30]. Mutational analysis has shown that this VP35 domain is important for suppression of type I IFN responses [30-32]. Because binding of dsRNA is one of the strategies to suppress RNA silencing, we wanted to investigate the importance of this domain in VP35-mediated RSS activity [33,34]. The VP35 dsRNA-binding domain has been identified as 304PRACQKSLRPV314. We tested two mutants containing a single amino acid substitution, K309A and R312A, and a double mutant, K309A/R312A. Furthermore, we tested the C-terminal deletion mutant R300T, which lacks 40 amino acids. Mutants K309A and K312A have a defect in dsRNA binding, whereas R300T lacks the complete dsRNA-binding domain [30,31]. The wild-type VP35 (VP35wt) and the various mutants were cloned in the expression vector pcDNA3.1 containing the cytomegalovirus (CMV) promoter. HEK293T cells were co-transfected with expression vectors for firefly luciferase, shLuc, the wild-type EBOV VP35wt, or the various mutants. In addition, a renilla luciferase expression plasmid (pRL-CMV) was co-transfected as internal control. Co-transfection of the firefly luciferase with shLuc resulted in a strong decrease of luciferase expression (Figure 2A). Addition of the VP35wt expression plasmid suppressed shRNA-mediated RNAi and restored luciferase expression. Interestingly, all mutants, in particular R312A, K309A/R312A, and R300T, were unable to rescue luciferase expression (Figure 2A). The internal renilla luciferase control was not affected by the various VP35 expression plasmids, and the firefly/renilla luciferase ratio showed a similar trend as the firefly luciferase data. These results indicate that dsRNA binding is essential for VP35-mediated RNAi suppression in the luciferase assay.
###end p 15
###begin p 16
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b027">27</xref>
###xml 314 322 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g002">Figure 2</xref>
###xml 523 525 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
To ensure that the effect of VP35wt is specific for the silenced luciferase, we tested the effect of VP35wt on luciferase expression in the presence of an inactive shRNA against luciferase, shLucR. In shLucR, the hairpin cassette has been inserted in reversed orientation, making it inactive as RNAi inducer [27] (Figure 2B). Co-transfection of the luciferase expression plasmid with shLucR did not affect luciferase expression, whereas shLuc induced a marked reduction in luciferase expression. Co-transfection of the VP35wt expression plasmid did not stimulate luciferase expression in the presence of shLucR, whereas it did enhance luciferase expression in the presence of shLuc. These results show that VP35-stimulated reporter expression is specific for an RNAi-silenced reporter.
###end p 16
###begin title 17
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Second Function of HIV-1 Tat Is Required for Virus Production
###end title 17
###begin p 18
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b017">17</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b035">35</xref>
###xml 660 668 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g003">Figure 3</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b036">36</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b037">37</xref>
###xml 1045 1047 1045 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1061 1063 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1094 1096 1094 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 1110 1112 1110 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 1180 1182 1180 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 1225 1227 1225 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1229 1237 1229 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g003">Figure 3</xref>
###xml 232 237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 299 303 <span type="species:ncbi:205488">EBOV</span>
###xml 370 375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 542 545 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1008 1011 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1049 1052 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1098 1101 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1213 1216 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1249 1252 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
RSS proteins derived from plant or insect viruses, but also NS1 and E3L, have been identified by their ability to functionally complement attenuated viruses that lack their own RSS [17,35]. Since it has recently been shown that the HIV-1 Tat protein has RSS activity, we wanted to determine whether EBOV VP35 is capable of functionally replacing the Tat RSS activity in HIV-1. To do this, one needs a Tat-minus virus, but such variants are completely replication impaired due to a transcription defect. However, we previously constructed the HIV-rtTA virus, in which Tat-mediated transcription transactivation is inactivated and replaced by the Tet-On system (Figure 3A) [36,37]. This virus is fully dependent on doxycycline (dox) for gene expression and replication. To test whether the Tat function can be removed in this context, we introduced a frame shift at Tat codon 20 by a single nucleotide deletion in the Tat open reading frame. Virus production was measured in HEK293T cells transfected with the HIV-rtTA molecular clone encoding Tatwt (HIV-rtTA-Tatwt) or the frame shift mutant Tatfs (HIV-rtTA-Tatfs). Both constructs produced virus in a dox-dependent manner, but Tatfs produced much less virus than HIV-rtTA-Tatwt (Figure 3B). Because HIV-rtTA is not dependent on Tat-mediated transcriptional activation, this result indicates that Tat is needed for an additional function.
###end p 18
###begin title 19
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Tat-Mediated Transactivation of Transcription and RNAi Suppression
###end title 19
###begin p 20
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 231 235 231 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 243 247 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b038">38</xref>
###xml 309 313 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 321 325 321 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 512 514 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 594 598 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 606 610 606 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 652 660 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g004">Figure 4</xref>
###xml 712 714 712 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 719 723 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 732 736 732 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 773 775 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 783 787 783 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 885 889 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 913 921 913 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g004">Figure 4</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b038">38</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b011">11</xref>
###xml 57 60 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 140 143 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 429 434 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 703 708 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To investigate whether the observed production defect of HIV-rtTA-Tatfs is caused by inactivation of Tat RSS activity, we studied rescue of HIV-rtTA-Tatfs by co-transfection of expression plasmids for Tatwt and two Tat mutants, TatF32A and TatY26A [38]. We first determined the transcriptional activity of TatF32A and TatY26A. For this, we used TZM-bl cells that contain the firefly luciferase reporter gene under control of the HIV-1 long terminal repeat (LTR), which is Tat responsive. Only transfection of Tatwt expression plasmid activated luciferase expression, whereas the Tat mutants TatF32A and TatY26A did not stimulate luciferase expression (Figure 4A). We next determined the RSS activity of HIV-1 Tatwt, TatF32A, and TatY26A using the luciferase RNAi assay. Tatwt and TatY26A were capable of suppressing shLuc-mediated silencing of the luciferase expression, but mutant TatF32A did not suppress RNAi (Figure 4B). Because both mutants express stable proteins that lack transactivation capacity [38], this result indicates that RSS activity can be separated from transcriptional activity, which is in agreement with the results described by Bennasser et al. in 2005 [11].
###end p 20
###begin p 21
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 125 127 125 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 132 136 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 144 148 144 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 163 167 163 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g004">Figure 4</xref>
###xml 319 323 319 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 441 443 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 515 518 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 279 282 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 429 432 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next determined whether the production defect of HIV-rtTA-Tatfs in HEK293T cells could be restored by co-expression of Tatwt, TatF32A, or TatY26A. Tatwt and TatY26A, which are capable of suppressing shRNA-mediated silencing of luciferase expression, rescued the production of HIV-rtTA-Tatfs (Figure 4C). However, TatF32A, which did not suppress RNAi, could not restore virus production. These data indicate that the defect in HIV-rtTA-Tatfs virus production is caused by a trans-acting RSS defect, rather than a cis-acting defect, of the frame shift mutation.
###end p 21
###begin title 22
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Complementation of HIV-rtTA-Tatfs by Heterologous RNAi Suppressor Proteins
###end title 22
###begin p 23
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 222 224 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 226 234 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g005">Figure 5</xref>
###xml 288 296 284 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g005">Figure 5</xref>
###xml 385 393 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g005">Figure 5</xref>
###xml 507 509 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 532 534 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 728 730 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 880 888 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g005">Figure 5</xref>
###xml 912 914 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 1052 1060 1048 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 1210 1218 1206 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g005">Figure 5</xref>
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 210 213 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 520 523 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 716 719 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1174 1179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We subsequently tested whether the HIV-rtTA-Tatfs production defect could also be restored by co-transfection of the EF1alpha expression plasmids for VP35, NS1, or E3L. Indeed, VP35 rescued virus production of HIV-rtTA-Tatfs (Figure 5A). Little RSS activity was measured for E3L and NS1 (Figure 5A), but increasing activity was measured when more RSS DNA was used in the transfection (Figure 5B). In the latter case, a GFP reporter was included as a negative control. To exclude that VP35, E3L, NS1, and Tatwt stimulate HIV-rtTA-Tatfs virus production by inducing promoter activity, we transfected cells with a firefly luciferase reporter under transcriptional control of the 8tetO promoter (the same promoter as in HIV-rtTA-Tatfs) with an rtTA expression plasmid and with the different RSS vectors. We measured dox-dependent promoter activity resulting in luciferase expression (Figure 5C). Co-expression of Tatwt, E3L, VP35, NS1, or GFP did not further increase luciferase expression, indicating that these proteins do no activate the 8tetO promoter in trans. The various RSS proteins also did not activate expression of a luciferase reporter under control of a wild-type HIV-1 LTR promoter in TZM-bl cells (Figure 5D). This shows that the observed rescue of the Tat function by the heterologous RSSs is independent of promoter activation.
###end p 23
###begin p 24
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 296 304 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g006">Figure 6</xref>
###xml 361 363 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 447 449 447 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 451 459 451 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g006">Figure 6</xref>
###xml 180 183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 349 352 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 435 438 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 568 573 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To confirm that the observed rescue of virus production corresponds with an increase in viral mRNAs, we analysed viral RNA accumulation by Northern blot analyses. First, rescue of HIV-rtTA-Tatfs virus production by Tatwt and VP35 was determined by measuring CA-p24 production in the supernatant (Figure 6A). The amount of full-length genomic RNA of HIV-rtTA-Tatfs accumulating in transfected cells was reduced when compared to that of HIV-rtTA-Tatwt (Figure 6B). In accordance with the CA-p24 values, co-transfection of Tat and VP35 restored the amount of full-length HIV-1 RNA.
###end p 24
###begin title 25
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 69 72 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
VP35 dsRNA-Binding Capacity Is Required for trans Complementation of HIV-rtTA-Tatfs
###end title 25
###begin p 26
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 197 199 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 232 234 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 240 242 240 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g007">Figure 7</xref>
###xml 317 319 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 371 373 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 453 455 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 108 111 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 167 170 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 185 188 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 359 362 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 441 444 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 728 733 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next, we wanted to determine whether the VP35 dsRNA-binding capacity is required for the complementation of HIV-rtTA-Tatfs. HEK293T cells were transfected with either HIV-rtTA-Tatwt or HIV-rtTA-Tatfs, and expression plasmids for Tatwt, VP35wt, and the VP35 mutants K309A, R312A, K309A/R312A, and R300T (Figure 7). Tatwt, VP35wt, and K309A were able to rescue HIV-rtTA-Tatfs production, and co-transfection of mutant R312A partially restored HIV-rtTA-Tatfs virus production. In contrast, mutants K309/R312A and R300T were unable to rescue virus production. These results correlate with the ability of the various VP35 mutants to suppress RNAi in the luciferase assay. Thus, the data confirm the importance of RNAi suppression in HIV-1 production and that the dsRNA-binding capacity of VP35 is essential for this activity.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b013">13</xref>
###xml 713 735 713 735 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b010">10</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b012">12</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b039">39</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b011">11</xref>
###xml 1554 1556 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b015">15</xref>
###xml 1920 1922 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b040">40</xref>
###xml 1923 1925 1923 1925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b041">41</xref>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 713 735 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 831 836 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although the importance of antiviral RNAi responses in plants, nematodes, and insects is firmly established, it is still under debate whether RNAi has a similar function in mammalian cells. If RNAi is a protective antiviral response in mammals, then virus infection should trigger the production of virus-specific siRNAs; inhibition of RNAi should affect virus replication, and viruses should have evolved factors that suppress RNAi [13]. To date, there are only three examples of virus-specific siRNAs accumulating in infected mammalian cells. The human retrotransposon LINE-1 was shown to be inhibited by transposon-specific siRNAs, which is similar to what was previously described for transposon silencing in Caenorhabditis elegans [10,12,39]. Furthermore, there is data suggesting accumulation of virus-specific siRNAs during HIV-1 replication [11]. However, virus-specific siRNA accumulation in mammalian cells appears to be relatively low compared to that in plant and insect cells. The reason for this has remained unclear. One explanation could be the lack of host RNA-dependent RNA polymerase (RdRp) activity in mammalian cells. In plants and insects, RdRp activity is responsible for amplification of the RNAi signal. In combination with viral RSS activity, the absence of RdRp activity could explain the low siRNA levels in mammalian cells in comparison to those in plant, insect, or nematode cells. Another possibility is that antiviral RNAi in mammalian cells is initiated by cellular microRNAs rather than by de novo production of siRNAs [15]. This has been suggested for the primate retrovirus PFV-1, where the cellular miR-32 was found to target PFV-1 sequences. PFV-1 overcomes microRNA-mediated antiviral pressure by the expressing the RSS Tas protein. In principle, viruses could also escape from antiviral microRNA pressure by acquisition of one or a few point mutations within the target sequence [40,41]. It is therefore likely that there is a more general RNAi response against PFV infection that necessitates the presence of an RSS.
###end p 28
###begin p 29
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b042">42</xref>
###xml 431 441 431 441 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">C. elegans</named-content>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b004">4</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b013">13</xref>
###xml 1573 1575 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b011">11</xref>
###xml 1761 1763 1761 1763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 401 427 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 431 441 <span type="species:ncbi:6239">C. elegans</span>
###xml 1194 1197 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1309 1314 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1400 1405 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1582 1585 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1628 1632 <span type="species:ncbi:205488">EBOV</span>
###xml 1700 1705 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1714 1718 <span type="species:ncbi:205488">EBOV</span>
###xml 1749 1752 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Little is known about enhanced virus replication in cells with a defective RNAi mechanism. However, recently it has been reported that HIV-1 replication is increased in human cells in which Dicer and Drosha expression is inhibited [42]. This suggests that RNAi indeed plays a central role in anti-HIV-1 defence responses in human cells. Another report describes enhanced accumulation of the mammalian vesicular stomatitis virus in C. elegans with a defective RNAi machinery, which confirms that RNAi has an antiviral activity in nematodes [4]. The other indication for RNAi-mediated antiviral activity in mammals is the fact that a number of mammalian viruses encode potent RSSs. However, it is still unclear to what extent these suppressors contribute to virus replication, because these factors have multiple functions that are difficult to separate. Moreover, the relevance of RSS activity measured in reporter assays has been questioned because non-specific binding of siRNAs by overexpression by dsRNA-binding proteins might also result in RNAi suppression [13]. Therefore, it is essential to test the importance of RSS activity in a viral context instead of in reporter assays. Using the HIV-rtTA virus as a tool to investigate RNAi suppression, we were able to separate the transactivation function of HIV-1 Tat from its RSS function. We showed that Tat-mediated RSS activity is essential for HIV-1 production without possible side effects of Tat-mediated transcriptional transactivation. These data are in agreement with data published by Bennasser et al. in 2005 [11]. The HIV-rtTA virus was used as a tool to identify EBOV VP35 protein as an RSS that can complement this Tat function. Both HIV-1 Tat and EBOV VP35 were found to complement HIV-rtTA-Tatfs production efficiently at low concentrations, indicating specific RSS activity. Moreover, RSSs encoded by other mammalian viruses are also able to complement the Tat RSS activity. The results presented here support the importance of RNAi in innate antiviral defence responses in mammalian cells and the essential function of RSSs in mammalian virus replication.
###end p 29
###begin p 30
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b043">43</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b044">44</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b045">45</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b046">46</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b044">44</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b047">47</xref>
In plants, insects, and nematodes, antiviral RNAi responses are triggered by virus-specific dsRNAs. In mammalian cells, virus-specific dsRNAs induce the IFN pathway via members of the Toll-like receptor family, or via a replication-dependent pathway involving the cytoplasmic dsRNA sensors RIG-I/MDA5 (retinoic-acid-inducible protein I/melanoma-differentiation-associated gene 5) [43,44]. Other antiviral proteins that are induced by dsRNA include the 2'-5' oligoadenylate cyclase (2'-5' OAS)/RNAseL and PKR [45,46]. Since RNAi, IFN responses, and 2'-5' OAS/RNAseL/PKR are triggered by dsRNA, it is likely that these pathways cooperate in the innate antiviral defence response. The helicases RIG-I/MDA5 are candidate proteins that could link antiviral RNAi and IFN responses because they can be activated by siRNAs [44,47].
###end p 30
###begin p 31
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b031">31</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b031">31</xref>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 1123 1131 1123 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030086-g008">Figure 8</xref>
###xml 60 64 <span type="species:ncbi:205488">EBOV</span>
###xml 592 595 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In agreement with this model is the recent observation that EBOV VP35 inhibits RIG-I induced activation of type I IFN responses [31]. In part, this inhibition is dependent on dsRNA-binding capacity of VP35 [31]. The K309A mutant was shown to have a partial defect in IFN antagonistic activity, whereas the other mutants, R312A, K309A/R312A, and R300T, were severely impaired in blocking IFN responses. Similarly, our assays show that mutation of the dsRNA-binding domain results in a loss of RNAi suppression activity. Only mutant K309A showed partial RSS activity and was able to complement HIV-rtTA-Tatfs production. These data suggest that VP35-mediated RNAi suppression and VP35-dsRNA-dependent IFN antagonistic properties are linked. We therefore propose that VP35 is able to sequester virus-specific siRNAs or dsRNA precursors of siRNA, resulting in suppression of an antiviral RNAi response that acts upstream of the 2'-5' OAS/RNAseL/PKR and IFN pathways. In this scenario, the amount of cytoplasmic virus-specific siRNAs needs to reach a certain threshold level before RIG-I/MDA5 and the IFN pathway are activated (Figure 8). In this way, virus-specific siRNAs would function as signal molecules for activation of the IFN response.
###end p 31
###begin p 32
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b048">48</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b049">49</xref>
Virus-mediated RNAi suppression therefore has two functions. First, it suppresses the RNAi response that acts as the first line antiviral defence. Second, the inhibition of siRNA accumulation prevents RIG-I/MDA5-mediated activation of the IFN pathway. Important in this respect are the immature plasmacytoid dendritic cells (PDCs), which play a predominant role in antiviral immunity. If the accumulation of virus-specific siRNAs in these cells is blocked by viral RSS activity, there will be no trigger to induce the secretion of class I IFNs that in turn induce a range of antiviral genes, resulting in the antiviral state of the neighbouring cells, dendritic cell maturation, and subsequent adaptive immunity [48]. This results in a delayed onset of the immune responses, and neighbouring cells will remain permissive to the invading virus for a prolonged time [49].
###end p 32
###begin p 33
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b050">50</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b056">56</xref>
###xml 188 193 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evasion of antiviral immune responses is a key process during virus replication. The results presented here suggest that RNAi plays an important role in innate antiviral defences and that HIV-1 needs to counter this mechanism in order to replicate. The fact that many RSS proteins also have IFN antagonistic properties [50-56] supports the idea that RNAi and IFN responses work together against invading viruses. It remains to be determined how the RNAi and IFN responses cooperate in mechanistic terms. In addition, future experiments should reveal the precise viral signature that activates the antiviral RNAi response in mammals.
###end p 33
###begin p 34
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b057">57</xref>
###xml 249 253 <span type="species:ncbi:205488">EBOV</span>
###xml 495 500 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 530 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 536 553 <span type="species:ncbi:12287">Flock house virus</span>
Although viral RSS factors will be able to counter RNAi during natural infections, these factors will likely not reduce the effectiveness of RNAi-based antiviral therapeutics. High concentrations of exogenous synthetic siRNAs, for example, to block EBOV replication will easily saturate the VP35 RSS activity, rendering VP35 ineffective, and subsequently still inhibit virus replication [57]. Similarly, plant viruses that encode RSS factors can also be silenced by RNAi, as can viruses such as HIV-1, influenza, hepatitis C virus, and Flock house virus that encode RSS factors.
###end p 34
###begin p 35
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
Besides revealing novel aspects of the virus-host interaction, the in trans complementation of viruses lacking their RSS by heterologous RSSs creates opportunities for improving production of virus particles in mammalian cells. Moreover, this phenomenon could be used to develop a new generation of live attenuated viral vaccines that improves upon the current antiviral measures.
###end p 35
###begin title 36
Materials and Methods
###end title 36
###begin title 37
Construction of expression plasmids.
###end title 37
###begin p 38
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b020">20</xref>
###xml 319 321 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 390 392 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 472 474 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b030">30</xref>
###xml 606 608 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b038">38</xref>
###xml 623 625 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 702 706 698 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 724 726 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b037">37</xref>
###xml 14 31 <span type="species:ncbi:11320">influenza A virus</span>
###xml 61 72 <span type="species:ncbi:205488">Ebola virus</span>
###xml 98 112 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 363 366 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 481 486 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 611 614 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 690 693 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The NS1 (from influenza A virus strain PR8 [20]), VP35 (from Ebola virus strain Zaire), E3L (from vaccinia virus strain Ankara), and EGFP open reading frames were cloned into the mammalian expression vector pEF5-V5-DEST containing human EF1alpha promoter using GATEWAY technology (Invitrogen, ). The constructs for VP35wt and the various VP35 mutants contain the CMV promoter (pcDNA3.1-VP35wt, K309A, R312A, K309A/R312A, and R300T) and were a kind gift from S. T. Nichol [30]. The HIV-1 Tat expression plasmids, pcDNA3-wtTat/pKV-wtTat, and the mutants, pcDNA3-Y26A and pKV-F32A, were described previously [38]. HIV-rtTA-Tatfs was created by deletion of A58 in the Tat open reading frame of HIV-rtTA-TatY26A (variant KYK in [37]), thus creating a frame shift at codon 20.
###end p 38
###begin title 39
Cell culture and transfections.
###end title 39
###begin p 40
###xml 322 323 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 452 453 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 920 922 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030086-b027">27</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 43 63 <span type="species:ncbi:9534">African green monkey</span>
###xml 158 162 <span type="species:ncbi:9913">calf</span>
Human embryonic kidney (HEK293T) cells and African green monkey kidney Vero cells were grown as a monolayer in DMEM (Gibco BRL, ) supplemented with 10% fetal calf serum (FCS) (Hyclone, ), minimal essential medium with non-essential amino acids, penicillin (100 U/ml), and streptomycin (100 mug/ml) at 37 degreesC and 5% CO2. One day before transfection, cells were trypsinized, resuspended in DMEM, and seeded in 24-well plates at a density of 1.5 x 105 cells per well. At the time of transfection, the cells were 60%-70% confluent. The transfection was performed in duplicates using Lipofectamine 2000 (Invitrogen) according to the instructions of the manufacturer. For the luciferase RNAi assay, cells were transfected with 100 ng of luciferase-expressing plasmid pGL3 (Promega, ) and 10 ng of expression plasmid shLuc (pShh1-Ff1), from which an shRNA against luciferase is expressed under control of the U6 promoter [27]. Cells were lysed 2-3 d post transfection in 150 mul of 1x Passive Lysis Buffer (Promega) by shaking for 30 min at room temperature. The cell lysate was centrifuged for 5 min at 1,500 rpm, and luciferase expression was measured in 10 mul of supernatant with the luciferase reporter assay system (Promega).
###end p 40
###begin p 41
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
For the complementation studies, 100 ng of HIV-rtTA-Tatfs was transfected with the indicated amounts of RSS plasmid. The total amount of DNA was brought to 1 mug using pBluescript (Stratagene, ). Two to three days after transfection, virus production was determined by measuring CA-p24 levels by enzyme-linked immunosorbent assay (ELISA).
###end p 41
###begin p 42
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 255 258 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 321 324 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
For the testing of the effect of Tat and the various RSS proteins on the 8tetO promoter, we transfected HEK293T cells with 20 ng of 8tetO-luc expression plasmid containing a luciferase reporter under control of the 8tetO promoter (the same promoter as in HIV-rtTA-Tatfs), 0.4 ng of rtTA expression plasmid, 0.5 ng of pRL-CMV, and the different RSS vectors. Two to three days after transfection, luciferase expression was measured.
###end p 42
###begin title 43
Transactivation assay.
###end title 43
###begin p 44
###xml 401 406 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Transcriptional transactivation capacity of Tat, Tat mutants, and the various RSS proteins was measured using TZM-bl cells. These cells were obtained from the NIH AIDS Research and Reference Reagent Program (also termed JC53-BL cells; catalog number 8129; ). TZM-bl cells are genetically modified Hela cells that express CD4, CXCR4, and CCR5 and contain the firefly reporter gene under control of the HIV-1 LTR, which is Tat responsive. The cells were seeded similarly to the HEK293T cells and transfected with 0.2 mug of Tat or RSS expression plasmid, and luciferase expression was measured 2-3 d after transfection.
###end p 44
###begin title 45
Northern blot analyses.
###end title 45
###begin p 46
###xml 71 73 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 87 89 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 107 109 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 146 148 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 923 925 914 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 75 78 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 95 98 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 244 247 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 456 461 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 794 799 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HEK293T cells (T25 flask) were transfected with 6.6 mug of HIV-rtTA-Tatwt, HIV-rtTA-Tatfs, and HIV-rtTA-Tatfs in combination with 0.132 mug of Tatwt or 0.132/0.66/1.32/6.6 mug of VP35 expression plasmid. Dox was added to the medium to activate HIV-rtTA virus production. Two to three days post transfection, virus production was measured via CA-p24 ELISA, and total RNA was isolated using the mirVana RNA isolation kit (Ambion, ). For detection of genomic HIV-1 RNAs, gel electrophoresis of 10 mug of total RNA was performed on a denaturing formaldehyde, 1% agarose gel. RNA was transferred to a positively charged nylon membrane (Boehringer, ) via capillary blotting and crosslinked to the membrane with a UV crosslinker (Stratagene). A 19-nt LNA-modified oligonucleotide complementary to the HIV-1 Nef gene was used as a probe, which was 5' end labeled using the kinaseMax kit (Ambion) in the presence of 1 mul of [gamma-32P]ATP (0.37 MBq/mul; Amersham Biosciences, ) and purified over a MicroSpin G-25 column (Amersham Biosciences). Prehybridization and hybridization was performed in Ultrahyb buffer (Ambion) at 60 degreesC for 30 min and 18 h, respectively. The membrane was washed twice for 15 min at 60 degreesC with high-stringency buffer (0.2x SSC, 0.2% SDS). Images were obtained using the Typhoon Trio phosphor imager (Amersham Biosciences).
###end p 46
###begin title 47
Supporting Information
###end title 47
###begin title 48
Accession Numbers
###end title 48
###begin p 49
###xml 90 104 <span type="species:ncbi:10245">vaccinia virus</span>
###xml 126 143 <span type="species:ncbi:11320">influenza A virus</span>
###xml 172 183 <span type="species:ncbi:205488">Ebola virus</span>
The GenBank () accession numbers for the proteins discussed in this article are E3L (from vaccinia virus) (U94848), NS1 (from influenza A virus) (EF467817), and VP35 (from Ebola virus) (AF086833).
###end p 49
###begin p 50
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
H. D. Klenk, Institut fur Virology, Phillips Universitat, Marburg, Germany, is thanked for donating the VP35 clone. S. T. Nichol, Centers for Disease Control and Prevention, Atlanta, United States of America, is thanked for donating the VP35wt and VP35 mutant expression plasmids. Stephan Heynen is thanked for CA-p24 ELISA.
###end p 50
###begin title 51
Abbreviations
###end title 51
###begin p 52
cytomegalovirus
###end p 52
###begin p 53
doxycycline
###end p 53
###begin p 54
double-stranded RNA
###end p 54
###begin p 55
###xml 0 11 <span type="species:ncbi:205488">Ebola virus</span>
Ebola virus
###end p 55
###begin p 56
###xml 0 14 <span type="species:ncbi:10245">vaccinia virus</span>
vaccinia virus E3L
###end p 56
###begin p 57
green fluorescent protein
###end p 57
###begin p 58
###xml 0 35 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
human immunodeficiency virus type 1
###end p 58
###begin p 59
interferon
###end p 59
###begin p 60
long terminal repeat
###end p 60
###begin p 61
###xml 0 17 <span type="species:ncbi:11320">influenza A virus</span>
influenza A virus NS1
###end p 61
###begin p 62
###xml 8 19 <span type="species:ncbi:11963">foamy virus</span>
primate foamy virus type 1
###end p 62
###begin p 63
protein kinase R
###end p 63
###begin p 64
retinoic-acid-inducible protein I/melanoma-differentiation-associated gene 5
###end p 64
###begin p 65
RNA interference
###end p 65
###begin p 66
RNA silencing suppressor
###end p 66
###begin p 67
short hairpin RNA
###end p 67
###begin p 68
firefly luciferase-specific shRNA
###end p 68
###begin p 69
small interfering RNA
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
###xml 78 88 78 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 78 88 <span type="species:ncbi:7227">Drosophila</span>
Essential function in vivo for Dicer-2 in host defense against RNA viruses in Drosophila
###end article-title 71
###begin article-title 72
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 66 76 <span type="species:ncbi:7227">Drosophila</span>
RNA interference directs innate immunity against viruses in adult Drosophila
###end article-title 72
###begin article-title 73
###xml 56 78 56 78 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 56 78 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
An antiviral role for the RNA interference machinery in Caenorhabditis elegans
###end article-title 73
###begin article-title 74
###xml 54 76 54 76 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 54 76 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
RNA interference is an antiviral defence mechanism in Caenorhabditis elegans
###end article-title 74
###begin article-title 75
Induction and suppression of RNA silencing: Insights from viral infections
###end article-title 75
###begin article-title 76
The tombusvirus-encoded P19: From irrelevance to elegance
###end article-title 76
###begin article-title 77
Hierarchical action and inhibition of plant Dicer-like proteins in antiviral defense
###end article-title 77
###begin article-title 78
RNA interference: Its use as antiviral therapy
###end article-title 78
###begin article-title 79
Identification of virus-encoded microRNAs
###end article-title 79
###begin article-title 80
###xml 73 78 <span type="species:ncbi:9606">human</span>
A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon
###end article-title 80
###begin article-title 81
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing
###end article-title 81
###begin article-title 82
###xml 86 91 <span type="species:ncbi:9606">human</span>
L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells
###end article-title 82
###begin article-title 83
Is RNA interference involved in intrinsic antiviral immunity in mammals?
###end article-title 83
###begin article-title 84
Plant pathogens and integrated defence responses to infection
###end article-title 84
###begin article-title 85
###xml 50 55 <span type="species:ncbi:9606">human</span>
A cellular microRNA mediates antiviral defense in human cells
###end article-title 85
###begin article-title 86
Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis
###end article-title 86
###begin article-title 87
Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing
###end article-title 87
###begin article-title 88
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response
###end article-title 88
###begin article-title 89
Suppression of RNA interference by adenovirus virus-associated RNA
###end article-title 89
###begin article-title 90
###xml 4 21 <span type="species:ncbi:11320">influenza A virus</span>
The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants
###end article-title 90
###begin article-title 91
###xml 4 15 <span type="species:ncbi:205488">Ebola virus</span>
The Ebola virus VP35 protein functions as a type I IFN antagonist
###end article-title 91
###begin article-title 92
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
###end article-title 92
###begin article-title 93
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase
###end article-title 93
###begin article-title 94
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR
###end article-title 94
###begin article-title 95
Double-stranded RNA-binding proteins could suppress RNA interference-mediated antiviral defences
###end article-title 95
###begin article-title 96
###xml 24 35 <span type="species:ncbi:205488">Ebola virus</span>
###xml 91 95 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice
###end article-title 96
###begin article-title 97
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
###end article-title 97
###begin article-title 98
###xml 65 70 <span type="species:ncbi:9606">human</span>
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants
###end article-title 99
###begin article-title 100
###xml 39 55 <span type="species:ncbi:186538">Zaire ebolavirus</span>
###xml 215 232 <span type="species:ncbi:11320">influenza A virus</span>
A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus
###end article-title 100
###begin article-title 101
###xml 0 11 <span type="species:ncbi:205488">Ebola virus</span>
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling
###end article-title 101
###begin article-title 102
Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication
###end article-title 102
###begin article-title 103
Small RNA binding is a common strategy to suppress RNA silencing by several viral suppressors
###end article-title 103
###begin article-title 104
Double-stranded RNA binding may be a general plant RNA viral strategy to suppress RNA silencing
###end article-title 104
###begin article-title 105
Induction and suppression of RNA silencing by an animal virus
###end article-title 105
###begin article-title 106
###xml 24 52 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Tat trans-activates the human immunodeficiency virus through a nascent RNA target
###end article-title 106
###begin article-title 107
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat
###end article-title 107
###begin article-title 108
###xml 65 100 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication
###end article-title 108
###begin article-title 109
###xml 28 50 28 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 28 50 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi
###end article-title 109
###begin article-title 110
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition
###end article-title 110
###begin article-title 111
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome
###end article-title 111
###begin article-title 112
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Suppression of microRNA-silencing pathway by HIV-1 during virus replication
###end article-title 112
###begin article-title 113
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
###end article-title 113
###begin article-title 114
A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells
###end article-title 114
###begin article-title 115
How cells respond to interferons
###end article-title 115
###begin article-title 116
###xml 49 53 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L
###end article-title 116
###begin article-title 117
###xml 79 96 <span type="species:ncbi:11103">hepatitis C virus</span>
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
###end article-title 117
###begin article-title 118
Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections
###end article-title 118
###begin article-title 119
Influenza virus evades innate and adaptive immunity via the NS1 protein
###end article-title 119
###begin article-title 120
Viruses and interferon: A fight for supremacy
###end article-title 120
###begin article-title 121
###xml 95 109 <span type="species:ncbi:10245">vaccinia virus</span>
Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus
###end article-title 121
###begin article-title 122
###xml 16 30 <span type="species:ncbi:10245">vaccinia virus</span>
The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
###end article-title 122
###begin article-title 123
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor
###end article-title 123
###begin article-title 124
###xml 43 60 <span type="species:ncbi:11320">influenza A virus</span>
The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway
###end article-title 124
###begin article-title 125
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme
###end article-title 125
###begin article-title 126
###xml 105 122 <span type="species:ncbi:11320">influenza A virus</span>
Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus
###end article-title 126
###begin article-title 127
###xml 27 38 <span type="species:ncbi:10141">guinea pigs</span>
###xml 56 67 <span type="species:ncbi:205488">ebola virus</span>
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference
###end article-title 127
###begin title 128
Figures and Tables
###end title 128
###begin title 129
RNAi Suppression by VP35, NS1, and E3L in Mammalian Cells
###end title 129
###begin p 130
HEK293T cells or Vero cells were transfected with an expression plasmid for firefly luciferase (Luc), a vector expressing an shRNA against luciferase (shLuc), expression constructs for various RSSs (VP35, NS1, E3L), or a control GFP expression plasmid. Luciferase expression was measured at 2-3 d post transfection.
###end p 130
###begin p 131
(A and B) Effect of VP35 (100, 300, and 600 ng) on the expression of the silenced luciferase reporter in HEK293T cells (A) and (B) Vero cells.
###end p 131
###begin p 132
(C and D) Effect of NS1, E3L, and GFP (600 ng) on expression of the silenced luciferase reporter in HEK293T cells (C) and in (D) Vero cells.
###end p 132
###begin title 133
VP35 dsRNA-Binding Capacity Is Required for RSS Activity
###end title 133
###begin p 134
###xml 112 114 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 103 107 <span type="species:ncbi:205488">EBOV</span>
###xml 252 255 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) HEK293T cells were co-transfected with expression vectors for firefly luciferase (Luc), shLuc, the EBOV VP35wt, or the various mutants (K309A, R312A, and K309/R12A), or a C-terminal deletion mutant R300T (50 ng). The renilla expression plasmid pRL-CMV was co-transfected as internal control. Luciferase expression was measured at 2-3 d post transfection. From the top down, the panels show the relative expression of firefly luciferase, renilla luciferase, and the ratio firefly/renilla.
###end p 134
###begin p 135
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
(B) HEK293T cells were co-transfected with expression vectors for firefly luciferase, renilla luciferase, and either the control shLucR, or the active shLuc in the presence and absence (-) of VP35wt expression plasmid. Luciferase expression was measured at 2-3 d post transfection. Shown is relative luciferase expression corrected for the internal renilla control (firefly/renilla).
###end p 135
###begin title 136
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Tat-Minus HIV-1 Complementation System
###end title 136
###begin p 137
###xml 21 24 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Schematic of the HIV-rtTA genome. In HIV-rtTA, the Tat-TAR transcriptional axis has been inactivated by mutation of both the Tat protein and the TAR hairpin (as indicated), and replaced by the tetracycline-inducible tetO-rtTA system. For this, the rtTA gene was inserted in place of the Nef gene and eight tetO sites were inserted in the LTR promoter. Upon administration of dox, rtTA can bind to tetO and activate transcription and viral replication. A frame shift mutation was introduced at codon 20 of the Tat gene.
###end p 137
###begin p 138
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 55 58 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 73 76 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) Virus production in HEK293T cells transfected with HIV-rtTA-Tatwt or HIV-rtTA-Tatfs in the absence (-) or presence (+) of dox. CA-p24 in the culture supernatant was measured at 3 d post transfection.
###end p 138
###begin title 139
###xml 47 50 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tat-Mediated RNAi Suppression Is Essential for HIV-rtTA Virus Production
###end title 139
###begin p 140
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 158 162 158 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 99 104 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) TZM-bl cells containing a Tat-responsive firefly luciferase reporter gene under control of the HIV-1-LTR were transfected with pBluescript (-), Tatwt, TatF32A, or TatY26A. Luciferase expression was determined 2 d post transfection.
###end p 140
###begin p 141
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 193 197 193 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
(B) Transfection of HEK293T cells with the luciferase reporter expression plasmid (Luc), the vector expressing an shRNA against luciferase (Luc + shLuc), and expression plasmids for Tatwt , TatF32A, or TatY26A. Luciferase expression was determined 2 d post transfection.
###end p 141
###begin p 142
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F32A</sup>
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y26A</sup>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(C) Virus production 2 d post transfection in HEK293T cells transfected with HIV-rtTA-Tatfs and expression plasmids for Tatwt, TatF32A, or TatY26A.
###end p 142
###begin title 143
Functional Complementation of the Tat RSS Function by VP35, NS1, and E3L
###end title 143
###begin p 144
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A and B) HEK293T cells were transfected with HIV-rtTA-Tatwt, HIV-rtTA-Tatfs, and expression plasmids for (A) Tatwt, VP35, E3L, and NS1 (50 ng) or (B) E3L, NS1, and GFP (10, 100, and 500 ng). Virus production was determined 2 d post transfection.
###end p 144
###begin p 145
###xml 215 218 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 267 270 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(C) To measure transcriptional transactivation capacity of the various proteins, HEK293T cells were transfected with a firefly luciferase reporter under control of the 8tetO promoter (similar to the promoter in the HIV-rtTA constructs), renilla expression vector pRL-CMV, an expression plasmid for rtTA to activate the promoter in the presence of dox, and the indicated amounts of RSSs. Luciferase expression (plotted as firefly/renilla) was determined 2 d post transfection. -, pBluescript (negative control).
###end p 145
###begin p 146
###xml 189 194 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(D) Transcriptional transactivation capacity of the various RSS proteins was measured using TZM-bl cells that contain a Tat-responsive firefly luciferase reporter gene under control of the HIV-1-LTR. The cells transfected with 0.2 mug of Tat or the indicated RSS expression plasmids. Two to three days after transfection, luciferase expression was measured. -, pBluescript (negative control).
###end p 146
###begin title 147
###xml 24 26 24 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 12 15 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analyses of HIV-rtTA-Tatfs Genomic RNA Accumulation Complemented with Tat and VP35
###end title 147
###begin p 148
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 40 43 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 56 59 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 76 79 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) HEK293T cells were transfected with HIV-rtTA-Tatwt, HIV-rtTA-Tatfs, and HIV-rtTA-Tatfs in combination with Tatwt or increasing amounts of VP35. Two to three days after transfection, virus production was measured via CA-p24 ELISA, and total RNA was isolated.
###end p 148
###begin p 149
###xml 259 261 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 247 250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(B) Total RNA (10 mug) was run on a denaturing agarose gel, and after blotting, probed with a Nef-specific radiolabeled probe. Relative genomic RNA accumulation was quantified by phosphorimaging and is indicated below. The RNA accumulation of the HIV-rtTA-Tatwt was set at 100%.
###end p 149
###begin title 150
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 69 72 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
VP35 dsRNA-Binding Capacity Is Required for trans Complementation of HIV-rtTA-Tatfs
###end title 150
###begin p 151
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 64 66 64 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fs</sup>
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sup>
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HEK293T cells were transfected with HIV-rtTA-Tatwt, HIV-rtTA-Tatfs, and expression plasmids for Tatwt, VP35wt, or the various VP35 mutants (K309A, R312A, and K309/R12A), or a C-terminal deletion mutant R300T (50 ng). Virus production was determined 2 d post transfection.
###end p 151
###begin title 152
Antiviral RNAi Activity and IFN Responses Function together in Innate Antiviral Defences
###end title 152
###begin p 153
During virus replication, virus-specific dsRNA molecules are generated that are recognized by Dicer and processed into siRNAs. One strand of the siRNA, the guide-strand, is loaded into RISC, which targets viral RNAs for destruction. To escape this antiviral pressure, viruses encode RSS factors that block the RNAi pathway. When virus-specific dsRNA molecules and siRNAs accumulate above a certain threshold, and consequently can no longer be masked by the viral RSS, the cytoplasmatic dsRNA sensors RIG-I/MDA5, PKR, and 2'5' OAS/RNAseL are activated. This results in the activation of range antiviral responses, including the production of type I IFNs, general translational inhibition, and RNA degradation. This model clarifies why RSSs like NS1, VP35, and E3L have been identified as IFN antagonists.
###end p 153
###begin p 154
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. JH, WdV, PdH, and BB conceived and designed the experiments. JH, WdV, and EJG performed the experiments. JH and WdV analyzed the data. JH, WdV, MP, PdH, and BB contributed reagents/materials/analysis tools. JH, WdV, PdH, and BB contributed to writing the paper.
###end p 154
###begin p 155
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This research is supported by Senter-NOVEM.
###end p 155
###begin p 156
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 156

